Flushing Hospital Medical Center Receives Get With The Guidelines Target Stroke Honor Roll-Elite Award

stroke award 2015 flushingFlushing Hospital Medical Center has received the American Heart Association/American Stroke Association’s Get With The Guidelines®–Target: Stroke Honor Roll-Elite Quality Achievement Award at the association’s International Stroke Conference 2015. The award recognizes the hospital’s commitment and success ensuring that stroke patients receive the most appropriate treatment according to nationally recognized and research-based guidelines.

The hospital is one of 559 hospitals to be recognized. To receive the Target: Stroke Honor Roll-Elite award, hospitals must meet quality measures developed to reduce the time between the patient’s arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke. Flushing Hospital has also met specific scientific guidelines as a Primary Stroke Center, featuring a comprehensive system for rapid diagnosis and treatment of stroke patients admitted to the emergency department.

These quality measures are designed to help hospital teams provide the most up-to-date, evidence-based guidelines with the goal of speeding recovery and reducing death and disability for stroke patients.

“We are pleased to recognize Flushing Hospital Medical Center for their commitment to stroke care,” said Deepak L. Bhatt, M.D., M.P.H., national chairman of the Get With The Guidelines steering committee and Executive Director of Interventional Cardiovascular Programs at Brigham and Women’s Hospital and Professor of Medicine at Harvard Medical School. “Studies have shown that hospitals that consistently follow Get With The Guidelines quality improvement measures can reduce length of stay and 30-day readmission rates and reduce disparities in care.”

For more hospital highlights, health and fitness tips: Follow and like Jamaica and Flushing Hospital on Facebook and Twitter.